Testing a new whole-body MRI scan for cancer
Part of Cancer clinical trials.
This study is testing a new, more detailed whole-body MRI scan to see how well it can take pictures of the body in people with certain cancers or genetic conditions that increase cancer risk. The goal is to improve early detection and monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with multiple myeloma, lymphoma, lung, prostate, breast, colorectal, or gynecologic cancer.
- Or you have a genetic condition like Li Fraumeni syndrome that makes you more likely to develop cancer.
- You are willing to sign a consent form allowing your medical information to be used for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses whole-body MRI to see if it can find health issues early in people without symptoms. The goal is to learn if this scan can help predict clinically important conditions in routine preventive care.
This study uses artificial intelligence to make whole-body MRI scans faster and more accurate. It may help find cancer earlier without needing contrast dyes or radiation.
This study is testing a new way to screen firefighters for cancer early, using special scans and blood tests. It aims to find cancer sooner so treatment can start earlier.
This study uses whole-body MRI scans to see if they help monitor or diagnose cancer better. It may be an option if your doctor has already recommended this type of scan.
This trial is testing a new way to use MRI scans to find breast cancer that has spread to other parts of the body early. It is for people who have had aggressive breast cancer (HER2 positive or triple negative) and finished treatment with surgery, but still have a higher risk of the cancer coming back.
This trial compares two whole-body imaging scans (full-body MRI using DWI and a PET/CT scan) to see which does a better job detecting and staging active multiple myeloma. If you have been newly diagnosed or are being evaluated for suspected symptomatic myeloma, joining could help doctors learn which test is best for planning your care.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.